The “innovation gap” is an increasingly important issue in the medical device industry. New life-impacting technologies…
A Novel Therapeutic Approach for Cryptococcal Meningitis
October 26, 2016 – Duke University School of Medicine/Minnetronix Neuro Cryptococcal meningitis (CM) is a devastating opportunistic infection that primarily…
Secrets of a CMO: What CardioFocus and Minnetronix learned over 16 years of partnership
Earlier this year, CardioFocus wowed the market when it won pre-market approval from the FDA for its HeartLight system, an endoscopically guided light energy device for the treatment of…
Minnesota Medical Companies Have Raised $227 Million This Year
Money is pouring into emerging Minnesota medical companies at a healthy rate. Golden Valley-based Medical Alley Association tallied a total of $227 million raised during the first half of…
Minnetronix Leverages NIH Funding for Success
The National Institutes of Health (NIH) funds the largest portion of public-sector health research in the U.S., and biomedical research…
Let’s talk about Media opportunities.
Call 612-578-2834 or email beth@LaBreche.com
We are here to help